DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology

0
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...

Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.

0
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....

Popular News

MAKE IT MODERN

LATEST REVIEWS

Precigen Inc (NASDAQ: PGEN) Announces Definitive Agreement For The Sale Of...

0
Precigen Inc (NASDAQ: PGEN) has announced a definitive agreement to sell its wholly-owned animal reproductive technology subsidiary Trans Ova Genetics L.C. to URUS for...

MAKE IT MODERN

PERFORMANCE TRAINING

MHRA Authorizes Sorrento Therapeutics Inc (NASDAQ: SRNE) To Conduct Phase 2 Efficacy Clinical Study...

0
The UK’s regulatory agency – MHRA (Medicines and Healthcare products Regulatory Agency), authorized Sorrento Therapeutics Inc (NASDAQ: SRNE) to commence phase 2 efficacy trial...

atai Life Sciences ‘(NASDAQ: ATAI) Philanthropic initiative Donates $500,000 To Multidisciplinary Association for Psychedelics

0
atai Life Sciences ‘(NASDAQ: ATAI) atai Impact, a philanthropic initiative, has announced the award of $500,000 to the Multidisciplinary Association for Psychedelics (MAPS). The...

Global Blood Therapeutics Inc. (NASDAQ:GBT) Reports $36.9 Million In Net Sales From Oxbryta® In...

0
Global Blood Therapeutics Inc. (NASDAQ:GBT) has announced its third quarter ended September 30 results and reported its corporate updates. GBT launched Oxbryta for SCD patients...

BioCryst Pharmaceutical Inc. (NASDAQ:BCRX) Announced Data For BCX9930 Clinical Trial In Treatment-Naïve PNH

0
BioCryst Pharmaceutical Inc. (NASDAQ:BCRX) has released new data from the treatment-naïve paroxysmal nocturnal hemoglobinuria (PNH)patients. This is for the patients who receive doses via...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Enters Commercialization Agreement with Otsuka Pharmaceuticals for Voclosporin

0
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) has announced the signing of a collaboration and license agreement with Otsuka Pharmaceutical Co. Ltd. The agreement is...

MAKE IT MODERN

POPULAR

romabet mahbet پین باهیس bettingmagazine.org بت کارت یاس بت yekbet megapari onjabet alvinbet betboro betfa بت فوروارد 1xbet 1win betwinner 4shart.com 1xbetgiris.cam وان کیک بت وین بت ریتزوبت 1xbet-ir.com.co وان ایکس بت بت فوروارد